Search

The European Parliament’s Research, Industry and Energy Committee has adopted a tough negotiating position on the EU’s next research funding programme.

EU budget negotiations may be stalled, with possible consequences for future R&D funding. But at least one collaborative science project – the European Space Agency - has agreed its long-term funding

University-industry partnerships have never been more important in developing a knowledge-based economy. This makes it critical to understand the drivers and barriers to effective collaboration, says Tatiana Schofield

UK start-up Breathing Buildings rethinks natural ventilation

European Medical Research Councils - along with learned societies and patients’ groups - make the case for changes to the Horizon 2020 proposals – calling for increased spending on biomedical science and the creation of a European Clinical Research Fund

Experts say cutting embryonic stem cell funding in Horizon 2020 will threaten progress Europe is making in developing safe, effective and well-regulated cell therapies - and in creating an economically important regenerative medicine sector

Europe currently leads the world in therapeutic applications of regenerative medicine. It has seen companies spin out from universities and approved products reaching the market. Science|Business brought together experts to discuss how to build on these foundations

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue

The EU must continue to support human embryonic stem cell research to maintain its lead in regenerative medicine. The upcoming Irish Presidency needs to recognise the importance of this research and resist calls for a ban on funding in Horizon 2020

Spin-out Liquid Light builds on research results that languished in the lab for 10 years – reverse combustion process produces methanol from CO2. Next step: industrial scale production.

Interview with Professor David Zilberman, professor of agricultural and resource economics at the University of California, Berkeley and principal investigator at the UC Berkeley Energy Biosciences Institute